These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2406872)

  • 21. Antimicrobial resistance and susceptibility testing of anaerobic bacteria.
    Schuetz AN
    Clin Infect Dis; 2014 Sep; 59(5):698-705. PubMed ID: 24867792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012.
    Lee Y; Park YJ; Kim MN; Uh Y; Kim MS; Lee K
    Ann Lab Med; 2015 Sep; 35(5):479-86. PubMed ID: 26206683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing.
    Barry AL; Draper DL; Wong MK
    Am J Clin Pathol; 1978 Nov; 70(5):821-5. PubMed ID: 717289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The sensitivity of anaerobic bacteria to chemotherapeutic agents (Zurich, 1991)].
    Wüst J; Hardegger U
    Schweiz Rundsch Med Prax; 1991 Dec; 80(52):1474-80. PubMed ID: 1815309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National hospital survey of anaerobic culture and susceptibility methods: III.
    Goldstein EJ; Citron DM; Goldman PJ; Goldman RJ
    Anaerobe; 2008 Apr; 14(2):68-72. PubMed ID: 18291689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the routine antimicrobial susceptibility testing results of clinically significant anaerobic bacteria in a Slovenian tertiary-care hospital in 2015.
    Jeverica S; Kolenc U; Mueller-Premru M; Papst L
    Anaerobe; 2017 Oct; 47():64-69. PubMed ID: 28433670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaerobic bacteria in postsurgical infections: isolation rate and antimicrobial susceptibility.
    Di Rosa R; Di Rosa E; Panichi G
    J Chemother; 1996 Apr; 8(2):91-5. PubMed ID: 8708752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of anaerobic bacteria in Australia.
    Chen SC; Gottlieb T; Palmer JM; Morris G; Gilbert GL
    J Antimicrob Chemother; 1992 Dec; 30(6):811-20. PubMed ID: 1289355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of faropenem activity against anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Bryskier A
    J Chemother; 2005 Feb; 17(1):36-45. PubMed ID: 15828442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility testing of anaerobes with Etest.
    Bolmström A
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S367-70. PubMed ID: 8324149
    [No Abstract]   [Full Text] [Related]  

  • 35. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis.
    Dornbusch K; Nord CE; Olsson B
    Scand J Infect Dis; 1975; 7(1):59-66. PubMed ID: 167431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the E test and a reference agar dilution method for susceptibility testing of anaerobic bacteria.
    Wüst J; Hardegger U
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1169-73. PubMed ID: 1291316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbroth versus agar dilution for susceptibility testing of fluoroquinolones and other agents against anaerobic bacteria.
    Krepel CJ; Gohr CM; Edmiston CE; Condon RE
    J Antimicrob Chemother; 1993 Oct; 32(4):571-5. PubMed ID: 8288498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of susceptibility testing methods for polymyxin.
    Behera B; Mathur P; Das A; Kapil A; Gupta B; Bhoi S; Farooque K; Sharma V; Misra MC
    Int J Infect Dis; 2010 Jul; 14(7):e596-601. PubMed ID: 20045367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.